Press Releases

Learn More

PRESS RELEASES

Kansas City, KS - (January 15, 2018) - Cingulate Therapeutics LLC a clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing its precision timed release drug delivery platform technology, today announced the presentation of a poster titled, “Pharmacoscintigraphic and Pharmacokinetic...

Kansas City, KS - (January 4, 2018) - Cingulate Therapeutics LLC, a clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing its precision timed release drug delivery platform technology, today announced the acceptance of data from its proof of concept...

Kansas City, KS - (November 15, 2017) - Cingulate Therapeutics, LLC, a clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing an innovative drug delivery platform technology, today announced the presentation of a poster titled, “Development and In Vivo Pharmacoscintigraphic...

Kansas City, KS - (June 19, 2017) - Cingulate Therapeutics, LLC, a privately held biopharmaceutical company focused on the development of new and innovative products for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), today announced that Shane J. Schaffer, PharmD, Chairman and Chief Executive Officer...